Vanguard Group Inc. Has $688.84 Million Stock Position in Chemed Corporation $CHE

Vanguard Group Inc. lowered its stake in shares of Chemed Corporation (NYSE:CHE) by 4.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,538,487 shares of the company’s stock after selling 64,084 shares during the quarter. Vanguard Group Inc. owned approximately 0.11% of Chemed worth $688,842,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. JPMorgan Chase & Co. grew its stake in shares of Chemed by 122.7% during the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock valued at $223,856,000 after purchasing an additional 275,423 shares during the last quarter. State of New Jersey Common Pension Fund D lifted its holdings in Chemed by 9.3% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 5,186 shares of the company’s stock worth $2,322,000 after buying an additional 441 shares in the last quarter. Illinois Municipal Retirement Fund boosted its position in Chemed by 15.9% in the 3rd quarter. Illinois Municipal Retirement Fund now owns 9,191 shares of the company’s stock valued at $4,115,000 after buying an additional 1,262 shares during the last quarter. Caprock Group LLC bought a new stake in shares of Chemed during the third quarter worth $641,000. Finally, Rhumbline Advisers raised its position in shares of Chemed by 0.9% during the third quarter. Rhumbline Advisers now owns 55,796 shares of the company’s stock worth $24,982,000 after acquiring an additional 518 shares during the last quarter. 95.85% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Jefferies Financial Group cut Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Royal Bank Of Canada reduced their target price on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research note on Monday, November 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Thursday, October 30th. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Chemed currently has an average rating of “Moderate Buy” and an average target price of $555.50.

Chemed Price Performance

Shares of CHE stock opened at $479.09 on Tuesday. The stock has a market cap of $6.78 billion, a PE ratio of 25.34, a price-to-earnings-growth ratio of 2.32 and a beta of 0.44. The stock has a 50-day moving average of $445.75 and a 200-day moving average of $443.99. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Monday, February 23rd will be issued a $0.60 dividend. The ex-dividend date is Monday, February 23rd. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s dividend payout ratio (DPR) is 12.69%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.